Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
MATR
WOOJUNG BIO
★

Kolmar BioTech Finalizes Merger Contract with Wholly Owned Subsidiary MOD Materials, No Share Issuance Protects Shareholder Value

  7h ago
MATR
WOOJUNG BIO
★

Kolma BioTech Decides to Absorb Wholly-Owned Subsidiary MOD Materials via Zero-Capital Merger, No New Shares Issued Thus No Dilution for Existing Shareholders

  07/20/2026 03:22 PM
EXCH
WOOJUNG BIO
★

WOOJUNG BIO Announces Head Office Building Name Change No Impact on Shareholder Value as Only Building Name Changes

  07/08/2026 05:42 PM
EXCH
WOOJUNG BIO
★

WOOJUNG BIO Changes Name to Kolmar BioTech to Enhance Brand Value

  07/08/2026 02:19 PM
EXCH
WOOJUNG BIO
★

WOOJUNG BIO EGM Approves Name Change and Business Diversification with Limited Share Price Impact

  07/08/2026 11:58 AM
OWNR
WOOJUNG BIO
★

WOOJUNG BIO Proposes Name Change to Kolmar BioTech, Business Diversification, and Appointment of Inside Director

  06/23/2026 02:33 PM
OTHR
WOOJUNG BIO
★

WOOJUNG BIO to Change Name to Kolmar BioTech and Diversify Business, Convening EGM

  06/23/2026 02:31 PM
EXCH
WOOJUNG BIO
★

WOOJUNG BIO Adjusts Conversion Price Upward, Reducing Potential Dilution and Benefiting Existing Shareholders

  06/09/2026 05:48 PM
OWNR
WOOJUNG BIO
★

Managing Director Sangsoo Lee Increases Stake in WOOJUNG BIO via Open Market Purchase, Limited Impact on Shareholder Value

  06/09/2026 03:56 PM
OWNR
WOOJUNG BIO
★

Woojung Bio Non-Registered Executive Ham Seok-hee Acquires 5000 Shares in Open Market Purchase, Indicating Insider Confidence and Minimal Dilution Impact

  06/04/2026 03:50 PM
OWNR
WOOJUNG BIO
★

Woojung Bio Non-Executive Director Sangsu Lee Acquires 8,247 Shares via Open Market Purchase, Signaling Confidence with Minimal Ownership Change

  06/04/2026 03:03 PM
FTC
WOOJUNG BIO
★

Woojung Bio Discloses Korea Kolmar Group Status - Confirms Weak Financials, Neutral Event

  06/01/2026 01:11 PM
EXCH
WOOJUNG BIO
★

WOOJUNG BIO Calls Extraordinary General Meeting: Name Change, Business Diversification, New Inside Director Appointment Proposed

  05/29/2026 01:33 PM
EXCH
WOOJUNG BIO
★

Record Date Set for Extraordinary General Meeting Voting... Routine Disclosure with No Shareholder Impact

  05/29/2026 01:31 PM
PERI
WOOJUNG BIO
★

Woojung Bio issues 35 billion won CB, changes largest shareholder to Kolmar Holdings… Sales continue to grow

  05/15/2026 02:26 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.